EOF is governed by a five-member Board of Directors. The current structure of EOF was determined by Presidential Decree 142/89 and consists of 9 Directorates.

To carry out its mission, EOF employs 190 employees, of whom 80 are pharmacists, chemists, doctors, veterinarians, biologists and 19 administrators, economists, mathematicians, computer scientists. At the same time, it collaborates with external scientists (approximately 400) of various specialties, participates in the committees and working groups of the competent bodies of the European Union and the Council of Europe with 45 representatives and has established 24 scientific Committees and Councils, consisting of expert scientists, the main ones of which are:

Scientific Approvals Council

It gives opinions on the approval, amendment, renewal, revocation and suspension of the marketing authorization of products under the jurisdiction of the Hellenic Medicines Authority. Various departments operate (conventional medicines, biologicals, blood products, radiopharmaceuticals, special nutritional products, veterinary medicines and veterinary vaccines).

Scientific and Ethical Committee for Clinical Trial Approvals

It ensures the protection of the rights, safety and health of individuals participating in the clinical trial.

National Prescription Committee

It compiles the National Formulary. A corresponding Committee also operates for the Veterinary Formulary.

Secondary Scientific Council

It examines appeals against first-instance decisions of the EOF.

Pharmacovigilance Committee

Evaluates adverse reactions and recommends measures or amendments to the Summary of Product Characteristics (SPC) and the Package Leaflet (PIL).

Pharmacopoeia Committee

Compiled the Greek Pharmacopoeia.

Cosmetics Committee

It consists of expert scientists and is tasked with proposing and processing issues related to the circulation of cosmetic products.

Medical Aid Committee

It recommends the classification of products as medical devices or not, their classification into categories, the definition and control of Notified Bodies and special regulations related to the implementation of the legislation.

Finally, EOF is assisted in its work by its subsidiary companies, mainly in matters of pharmacoeconomics, research and covering market deficiencies, as described in more detail below.

  • Institute of Pharmaceutical Research and Technology (IFET) S.A.

    Assist the work of EOF by preparing statistical and econometric analyses, studies, research programs and applications of organizations and computerization. IFET has also undertaken the distribution of products under the jurisdiction of EOF for its own account or on behalf of third parties to cover permanent or extraordinary market shortages.
  • National Center for the Evaluation of Quality and Technology in Health (EKAPTY S.A.)

    Its main activity is certification, quality control and research on medical devices. It has been a notified body of the European Union since 1997 in the field of medical devices.
  • EOF resources

    The Agency's resources consist of fees for various services it offers (approvals, renewals, amendments to marketing authorizations, production authorizations, certificates, invoice approvals) regarding products under its jurisdiction and the annual fixed fee paid by those responsible for marketing the products (reciprocal fee, pharmaceutical legislation fines, etc.).